1. Home
  2. CTXR vs CYCU Comparison

CTXR vs CYCU Comparison

Compare CTXR & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • CYCU
  • Stock Information
  • Founded
  • CTXR 2007
  • CYCU N/A
  • Country
  • CTXR United States
  • CYCU United States
  • Employees
  • CTXR N/A
  • CYCU N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • CYCU
  • Sector
  • CTXR Health Care
  • CYCU
  • Exchange
  • CTXR Nasdaq
  • CYCU Nasdaq
  • Market Cap
  • CTXR 14.6M
  • CYCU 15.0M
  • IPO Year
  • CTXR N/A
  • CYCU N/A
  • Fundamental
  • Price
  • CTXR $0.86
  • CYCU $0.41
  • Analyst Decision
  • CTXR Strong Buy
  • CYCU
  • Analyst Count
  • CTXR 3
  • CYCU 0
  • Target Price
  • CTXR $54.50
  • CYCU N/A
  • AVG Volume (30 Days)
  • CTXR 153.2K
  • CYCU 2.6M
  • Earning Date
  • CTXR 05-14-2025
  • CYCU 06-06-2025
  • Dividend Yield
  • CTXR N/A
  • CYCU N/A
  • EPS Growth
  • CTXR N/A
  • CYCU N/A
  • EPS
  • CTXR N/A
  • CYCU 0.02
  • Revenue
  • CTXR N/A
  • CYCU $17,771,485.00
  • Revenue This Year
  • CTXR N/A
  • CYCU N/A
  • Revenue Next Year
  • CTXR N/A
  • CYCU N/A
  • P/E Ratio
  • CTXR N/A
  • CYCU $28.33
  • Revenue Growth
  • CTXR N/A
  • CYCU N/A
  • 52 Week Low
  • CTXR $0.65
  • CYCU $0.26
  • 52 Week High
  • CTXR $26.25
  • CYCU $10.99
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 51.82
  • CYCU N/A
  • Support Level
  • CTXR $0.80
  • CYCU N/A
  • Resistance Level
  • CTXR $0.92
  • CYCU N/A
  • Average True Range (ATR)
  • CTXR 0.08
  • CYCU 0.00
  • MACD
  • CTXR 0.03
  • CYCU 0.00
  • Stochastic Oscillator
  • CTXR 62.41
  • CYCU 0.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About CYCU Cycurion Inc. Common Stock

Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

Share on Social Networks: